PX, T., TDD, B., & EY, M. (2022). Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 150, 113021. https://doi.org/10.1016/j.biopha.2022.113021
Chicago Style (17th ed.) CitationPX, Thuy, Bao TDD, and Moon EY. "Ursodeoxycholic Acid Ameliorates Cell Migration Retarded by the SARS-CoV-2 Spike Protein in BEAS-2B Human Bronchial Epithelial Cells." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 150 (2022): 113021. https://doi.org/10.1016/j.biopha.2022.113021.
MLA (9th ed.) CitationPX, Thuy, et al. "Ursodeoxycholic Acid Ameliorates Cell Migration Retarded by the SARS-CoV-2 Spike Protein in BEAS-2B Human Bronchial Epithelial Cells." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 150, 2022, p. 113021, https://doi.org/10.1016/j.biopha.2022.113021.